Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective

Journal of Medicinal Chemistry
Tianfang MaXiaoming Zha

Abstract

Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH1/2) reduces α-KG to the oncometabolite 2-hydroxyglutarate (2-HG). High levels of 2-HG competitively inhibit the α-KG-dependent dioxygenases involved in histone and DNA demethylation, thereby impairing normal cellular differentiation and promoting tumor development. Thus, small molecules that inhibit these mutant enzymes may be therapeutically beneficial. Recently, an increasing number of mIDH1/2 inhibitors have been reported. In this review, we summarize the molecular basis of mIDH1/2 and the activity, binding modes, and progress in clinical application of mIDH1/2 inhibitors. We note important future research directions for mIDH1/2 inhibitors and discuss potential therapeutic strategies for the development of mIDH1/2 inhibitors to treat IDH1/2 mutated tumors.

References

Nov 6, 2008·Acta Neuropathologica·Jörg BalssAndreas von Deimling
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Nov 26, 2009·Nature·Lenny DangShinsan M Su
Apr 20, 2010·Cancer Cell·Houtan NoushmehrUNKNOWN Cancer Genome Atlas Research Network
Jun 2, 2010·Journal of the National Cancer Institute·Zachary J Reitman, Hai Yan
Jun 19, 2010·Nature·Lenny DangShinsan M Su
Sep 30, 2010·Neuropathology and Applied Neurobiology·S PuschA von Deimling
Jul 24, 2012·Cell·John S WelchRichard K Wilson
Oct 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hui YangYue Xiong
Jun 25, 2013·ACS Medicinal Chemistry Letters·Baisong ZhengYongcheng Song
Mar 7, 2014·Current Hematologic Malignancy Reports·Heiko Konig, Mark Levis
May 27, 2014·American Society of Clinical Oncology Educational Book·Karilyn Larkin, William Blum
Oct 11, 2012·ACS Medicinal Chemistry Letters·Janeta Popovici-MullerShinsan M Su
Oct 18, 2014·Frontiers in Oncology·Javier A Menendez, Tomás Alarcón
Mar 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Makoto HirataBenjamin A Alman
Jun 11, 2015·The New England Journal of Medicine·Jeanette E Eckel-PassowRobert B Jenkins
Aug 19, 2015·Journal of Medicinal Chemistry·Fangrui WuYongcheng Song
Oct 6, 2015·Nature Chemical Biology·Ujunwa C Okoye-OkaforUlrich Steidl
Nov 23, 2015·Best Practice & Research. Clinical Haematology·Eytan M Stein
Dec 19, 2015·Cancer Cell·Kensuke TateishiDaniel P Cahill
Jan 29, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Owen ClarkIngo K Mellinghoff
Mar 24, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L DangE C Attar
May 31, 2016·Cell·Alan MerkSriram Subramaniam
Jun 14, 2016·Mini Reviews in Medicinal Chemistry·Jiao ChenPeng Cao
Oct 25, 2016·ACS Medicinal Chemistry Letters·Jason M LawStuart L Schreiber

❮ Previous
Next ❯

Citations

Mar 13, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bozena KaminskaBartlomiej Gielniewski
Aug 16, 2019·Pharmaceutical Patent Analyst·William P Katt, Richard A Cerione
Jan 22, 2020·Expert Opinion on Biological Therapy·David B AltshulerMaria G Castro
Jun 1, 2021·Signal Transduction and Targeted Therapy·Lei ZhongShengyong Yang
Aug 25, 2021·Journal of Experimental & Clinical Cancer Research : CR·Kun YaoHong Tao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Hui YangYue Xiong
Chinese Clinical Oncology
Catherine H Han, Tracy T Batchelor
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Lenny DangE C Attar
© 2022 Meta ULC. All rights reserved